Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Eriksson C, Rundquist S, Lykiardopoulos V, Udumyan R, Karlén P, Grip O, Söderman C, Almer S, Hertervig E, Marsal J, Gunnarsson J, Malmgren C, Delin J, Strid H, Sjöberg M, Öberg D, Bergemalm D, Hjortswang H, Halfvarson J; SWIBREG SVEAH Study Group.
Eriksson C, et al. Among authors: delin j.
Therap Adv Gastroenterol. 2021 Jul 3;14:17562848211023386. doi: 10.1177/17562848211023386. eCollection 2021.
Therap Adv Gastroenterol. 2021.
PMID: 34276808
Free PMC article.